A. Cascino

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A Cascino, A. Cascino, Antonia Cascino
Publication record
100 papers · 1,853 citations · H-index 29

PAPERS

Left ventricular mass correlates with lean body mass in patients with disease-associated wasting
201414 citationsauthor #6
Not just a simple case of sinusitis
20130 citationsauthor #5
Comparison of the performance of four different tools in diagnosing disease-associated anorexia and their relationship with nutritional, functional and clinical outcome measures in hospitalized patients.
201334 citationsauthor #5
PP171-MON COMPARISON OF THE PERFORMANCE OF DIFFERENT SCREENING TOOLS IN IDENTIFYING MALNUTRITION AND FUNCTIONAL IMPAIRMENT IN HOSPITALIZED PATIENTS
20130 citationsauthor #5
PP176-SUN NUTRITIONAL RISK IS UNDERDIAGNOSED IN HOSPITALIZED PATIENTS, BUT NEGATIVELY AFFECTS CLINICAL OUTCOME: COMPARISON BETWEEN NUTRITION SCREENING TOOLS AND PHASE ANGLE
20131 citationsauthor #5
Brain serotonin and the control of food intake under physiological and pathological conditions
20120 citationsauthor #5
Novel therapeutic strategies to improve deranged metabolism in chronic diseases: the potential role of carnitine and nicotine
20121 citationsauthor #3
PP119-SUN THE ESPEN ANOREXIA SCORE IS RELATED TO HANDGRIP STRENGTH IN UNSELECTED MEDICAL PATIENTS
20110 citationsauthor #3
Chronic Renal Failure, Cachexia, and Ghrelin
201020 citationsauthor #5
Metabolic effects of glutamine on insulin sensitivity
201012 citationsauthor #4
Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism.
201058 citationsauthor #2
Tryptophan in wasting diseases: at the crossing between immune function and behaviour
200916 citationsauthor #3
The driving brain: the CNS in the pathogenesis and treatment of anorexia–cachexia syndrome
20090 citationsauthor #2
Anorexia of Aging
200910 citationsauthor #2
P075 Pathogenesis, Prevalence and Impact of Anorexia in the Elderly
20080 citationsauthor #15
L-CARNITINE ADMINISTRATION IMPROVES INSULIN SENSITIVITY IN PATIENTS WITH IMPAIRED GLUCOSE METABOLISM
20081 citationsauthor #2
Free tryptophan/large neutral amino acids ratios in blood plasma do not predict cerebral spinal fluid tryptophan concentrations in interleukin-1-induced anorexia.
200810 citationsauthor #3
Antimyopathic effects of carnitine and nicotine
200633 citationsauthor #5
The Role of Branched-Chain Amino Acids and Serotonin Antagonists in the Prevention and Treatment of Cancer Cachexia
20063 citationsauthor #2
Branched-chain amino acids: the best compromise to achieve anabolism?
200593 citationsauthor #3
The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects
200547 citationsauthor #4
Plasma and CSF tryptophan in cancer anorexia
200545 citationsauthor #2
Anorexia and serum leptin levels in hemodialysis patterns. Commentary
20041 citationsauthor #6
Anorexia and Serum Leptin Levels in Hemodialysis Patients
200432 citationsauthor #6
Anorexia and serum leptin levels in hemodialysis patients.
200345 citationsauthor #6
Tumor-induced changes in host metabolism: a possible role for free tryptophan as a marker of neoplastic disease.
200332 citationsauthor #2
CASE REPORT: Ursodeoxycholic Acid Treatment in Abdominal Sarcoidosis
200012 citationsauthor #2
[Pathogenetic and therapeutic aspects of secondary anorexia].
20001 citationsauthor #2
Serum tumour necrosis factor‐α levels in cancer patients are discontinuous and correlate with weight loss
200043 citationsauthor #5
HCV hepatitis and polyarthritis: a therapeutic approach.
20001 citationsauthor #5
Ursodeoxycholic acid treatment in abdominal sarcoidosis.
200018 citationsauthor #2
THE BASIS FOR A RATIONAL NUTRITIONAL APPROACH TO PATIENTS WITH CANCER
19997 citationsauthor #4
Effect of cisplatin and paclitaxel on plasma free tryptophan levels. An in vitro study.
19993 citationsauthor #3
The basis for a rational approach to patients with cancer
19990 citationsauthor #4
Plasma amino acid concentrations in patients with acute myelogenous leukemia.
199926 citationsauthor #5
Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients
199864 citationsauthor #6
Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity.
199732 citationsauthor #7
[Energy metabolism in cancer patients].
19977 citationsauthor #2
Plasma tryptophan levels and anorexia in liver cirrhosis.
199755 citationsauthor #6
Cancer anorexia: new pathogenic and therapeutic insights.
199625 citationsauthor #5
O.30 Serotonin in the ventro-medial hypothalamus (VMH) influences anorexia in tumour bearing (TB) rats
19960 citationsauthor #4
Tryptophan and secondary anorexia.
19965 citationsauthor #4
Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats.
199617 citationsauthor #7
Tumor-induced changes in host metabolism: a possible marker of neoplastic disease.
199548 citationsauthor #6
O.17 Effects of oral glutamine on high-dosechemotherapy (HDCT)-induced gastrointestinal toxicity in acute leukemia patients: a pilot study
19953 citationsauthor #5
Plasma amino acid imbalance in patients with lung and breast cancer.
199596 citationsauthor #1
0.63 Plasma concentrations of taurine and otheramino acids in patients with acute leukemias
19950 citationsauthor #6
Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation.
199446 citationsauthor #7
PLASMA-FREE TRYPTOPHAN IN PATIENTS WITH CANCER
19940 citationsauthor #1
PLASMA-FREE AMINO-ACID ALTERATIONS OCCUR EARLY DURING TUMOR-GROWTH
19943 citationsauthor #6
Effects of oral branched-chain amino acids (BCAA) administration in the treatment of cancer anorexia
19943 citationsauthor #6
Synergism between different transport systems stimulates the uptake of neutral amino acids by isolated brain microvessels
19921 citationsauthor #6
Tryptophan, cytokines and anorexia in cancer patients before and after surgical tumor eradication
19921 citationsauthor #8
Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.
1992108 citationsauthor #3
Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients.
199149 citationsauthor #5
Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects.
199120 citationsauthor #4
Plasma tryptophan (TRP) levels and anorexia in liver cirrhosis
19911 citationsauthor #4
Cell kinetics of gastrointestinal tumors after different nutritional regimens. A preliminary report.
19919 citationsauthor #4
Increased plasma free tryptophan levels in human cancer: a tumor related effect?
199136 citationsauthor #1
The methionine analog S-methylthiocysteine stimulates neutral amino acid transport by isolated brain microvessels
19911 citationsauthor #4
Abnormal substrate metabolism and nutritional strategies in cancer management.
199117 citationsauthor #2
Unliability of biochemical parameters in the nutritional assessment of patients undergoing allogeneic bone marrow transplantation (BMT) for leukemia
19902 citationsauthor #4
Plasma amino acid (AA) levels in lung (LC) and breast (BC) cancer
19900 citationsauthor #2
Plasma clearance of exogenous lipids in patients with malignant disease.
199020 citationsauthor #3
[Metabolico-nutritional changes in the cancer patient].
19890 citationsauthor #4
Plasma Amino-acids in Human Cancer: the Individual Role of Tumour, Malnutrition and Glucose Tolerance -
198810 citationsauthor #1
Uptake of Amino Acids by Brain Micro vessels Isolated from Rats with Experimental Chronic Renal Failure
198817 citationsauthor #3
Effect of exogenous triglyceride infusion on the plasma amino-acid profile in liver cirrhosis
19886 citationsauthor #4
5-HYDROXYTRYPTOPHAN ADMINISTRATION AND ANOREXIA IN HYPERPHAGIC OVERWEIGTH PATIENTS
19870 citationsauthor #3
Amino acids and hepatic encephalopathy.
198724 citationsauthor #2
Exogenous lipid clearance in compensated liver cirrhosis.
198630 citationsauthor #3
Plasma and CSF tryptophan in patients with cancer anorexia
19863 citationsauthor #2
Plasma tryptophan and anorexia in human cancer.
198668 citationsauthor #8
Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.
198634 citationsauthor #4
Brain Dysfunction in Respiratory Failure
19840 citationsauthor #2
Long Term Dietary Supplement with Branched Chain Amino Acids: A New Approach in the Prevention of Hepatic Encephalopathy: Results of a Controlled Study in Cirrhotics with Porto-Caval Anastomosis
198415 citationsauthor #3
Branched-Chain Amino Acids in the Treatment of Severe Hepatic Encephalopathy
19849 citationsauthor #3
Plasma tryptophan and anorexia in cancer patients
19841 citationsauthor #1
Cerebro-Spinal Fluid Amino Acid Pattern in Hepatic Encephalopathy
19843 citationsauthor #2
The Pros and the Cons of the Amino Acid Neurotransmitter Hypothesis
19840 citationsauthor #4
Plasma aminoacid levels across the brain in patients with respiratory failure
19830 citationsauthor #6
On the stimulation by insulin of tryptophan transport across the blood-brain barrier.
198333 citationsauthor #3
Effects of Branched Chain Amino Acids on Biochemical Variables and Clinical Symptoms of Hepatic Encephalopathy
19830 citationsauthor #3
Branched-chain amino acids vs lactulose in the treatment of hepatic coma
198232 citationsauthor #4
Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy
198230 citationsauthor #1
Glucose intolerance in liver cirrhosis.
198275 citationsauthor #5
Plasma levels of false neurotransmitters across the brain in portal‐systemic encephalopathy
198214 citationsauthor #5
Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure.
198131 citationsauthor #4
Is the blood-brain barrier really intact in portal-systemic encephalopathy?
198110 citationsauthor #2
[Pathogenesis of hepatic coma].
19811 citationsauthor #3
Influence of phenylethanolamine on octopamine plasma determination in hepatic encephalopathy.
197917 citationsauthor #3
Amino acids containing pharmaceutical of preparation
19790 citationsauthor #5
Tryptophan and hepatic encephalopathy.
19793 citationsauthor #3
Plasma amino acids imbalance in patients with liver disease
197830 citationsauthor #1
Plasma phenylethanolamine in hepatic encephalopathy
197812 citationsauthor #5
Octopamine and ammonia plasma levels in hepatic encephalopathy.
197720 citationsauthor #5
Octopamine plasma levels and hepatic encephalopathy: a re-appraisal of the problem.
197636 citationsauthor #5
[Physiopathology of ammonia].
19760 citationsauthor #2
[Clinical use of a test for determination of coagulation factors II, X and VII].
19750 citationsauthor #1
[Octopamine content of human blood].
19741 citationsauthor #3

TIMELINE

1974 1 citations

1975 0 citations

1976 36 citations

1977 20 citations

1978 42 citations

1979 20 citations

1981 42 citations

1982 151 citations

1983 33 citations

1984 28 citations

1986 135 citations

1987 24 citations

1988 33 citations

1989 0 citations

1990 22 citations

1991 133 citations

1992 110 citations

1994 52 citations

1995 147 citations

1996 47 citations

1997 94 citations

1998 64 citations

1999 36 citations

2000 75 citations

2003 77 citations

2004 33 citations

2005 185 citations

2006 36 citations

2008 11 citations

2009 26 citations

2010 90 citations

2011 0 citations

2012 1 citations

2013 35 citations

2014 14 citations

A. Cascino

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT